| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.955 | 1 | 1 | 1988 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 3 | 2 | 1989 | 2020 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.150 | None | 1.000 | 2 | 2 | 1989 | 2019 | |||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.946 | 2 | 1 | 1989 | 2019 | ||||||||
|
deleted in lymphocytic leukemia 1 | 0.569 | 0.692 | 0.47 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 1989 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 1989 | 2016 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
group | 0.130 | None | 1.000 | 1 | 1 | 1989 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.500 | None | 0.960 | 1 | 1 | 1989 | 2019 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
group | 0.500 | None | 1.000 | 1 | 1 | 1989 | 2019 | ||||||||
|
dynactin subunit 4 | 0.472 | 0.846 | 0.73 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 1989 | 2018 | ||||||||
|
thyroglobulin | 0.480 | 0.808 | 2.9E-59 |
|
disease | 0.200 | None | 0.969 | 1 | 1 | 1989 | 2019 | ||||||||
|
ribonuclease P/MRP subunit p14 | 0.544 | 0.808 | 1.9E-03 |
|
disease | 0.120 | None | 1.000 | 3 | 1 | 1990 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.976 | 3 | 2 | 1990 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.200 | None | 0.970 | 3 | 2 | 1990 | 2020 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.120 | None | 1.000 | 2 | 3 | 1990 | 2015 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.882 | 2 | 2 | 1990 | 2019 | ||||||||
|
solute carrier family 2 member 2 | 0.572 | 0.692 | 3.4E-08 |
|
disease | 0.700 | None | 0.839 | 2 | 1 | 1990 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.962 | 1 | 1 | 1990 | 2016 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.800 | strong | 0.972 | 1 | 1 | 1990 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.900 | None | 0.982 | 1 | 1 | 1990 | 2019 | ||||||||
|
aryl-hydrocarbon receptor repressor | 0.666 | 0.577 | 1.8E-04 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 1990 | 2017 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.500 | None | 0.966 | 1 | 1 | 1990 | 2020 | ||||||||
|
transcription factor 3 | 0.476 | 0.846 | 2.6E-02 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 1990 | 2014 | ||||||||
|
KRIT1 ankyrin repeat containing | 0.500 | 0.808 | 6.9E-04 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 1990 | 2017 | ||||||||
|
clusterin | 0.426 | 0.885 | 7.8E-05 |
|
disease | 0.500 | None | 0.940 | 9 | 7 | 1991 | 2020 |